Effects of hyperthermia on bioenergetic status and phosphorus T1S in human melanoma xenografts monitored by 31P-MRS

Magnetic Resonance Imaging

Volumn 17, Issue 7, 1999, Pages 1049-1056

  Olsen, Dag R ^a   Singstad, Trond E ^b   Rofstad, Einar K ^a  

^a INSTITUTE OF CANCER RESEARCH   (Norway)

^b SINTEF   (Norway)

Author keywords

31P MR spectroscopy; Blood flow; Human melanoma xenografts; Hyperthermia

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENERGY; CAPILLARY FLOW; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; MALE; MELANOMA; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR BLOOD FLOW; TUMOR XENOGRAFT;

ANIMALS; CAPILLARIES; ENERGY METABOLISM; HUMANS; HYPERTHERMIA, INDUCED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PHOSPHOCREATINE; REGIONAL BLOOD FLOW; VASODILATION;

ANIMALIA;

EID: 0032851711     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(99)00032-6     Document Type: Article

References (35)

1. Overgaard J. Hyperthermic modification of the radiation response in solid tumors. Fletcher G.H., Arcangeli G., Nervi F. Biological Basis and Clinical Implications of Tumor Radioresistance. 1983;337-352 Masson, New York.
2. Horsman M.R., Overgaard J. Thermal radio-sensitization in animal tumours The potential for therapeutic gain . Urano M., Douple E.B. Hyperthermia and Oncology. 1989;113-145 VSP, Utrecht.
3. Oleson J.R. Hyperthermia. DeVita V.T., Hellman S., Rosenberg S.A. Cancer Principles and Practice of Oncology . Vol. 4:1993;2752-2783 Lippincott, Philadelphia.
4. Oleson J.R. Hyperthermia from the clinic to the laboratory: a hypothesis. Int. J. Hyperthermia. 11:1995;315-322.
5. Mackey M.A. The success of clinical hyperthermia. Int. J. Hyperthermia. 12:1996;169-171.
6. Ryu S., Brown S.L., Kolozsvary A., Kim J.H. Increased tumour response of a murine fibrosarcoma to low temperature hyperthermia and low dose rate brachy-therapy. Int. J. Hyperthermia. 12:1996;635-643.
7. Horsman M.R., Overgaard J. Can mild hyperthermia improve tumour oxygenation? Int. J. Hyperthermia. 13:1997;141-147.
8. Masunaga S., Ono K., Akaboshi M., Nishimura Y., Suzuki M., Kinashi Y., Takagaki M., Hiraoka M., Abe M. Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: Special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations. Br. J. Cancer. 76:1997;588-593.
9. 2) and radiosensitiviy. Cancer Res. 56:1996;5590-5593.
10. Brizel D.M., Scully S.P., Harrelson J.M., Layfield L.J., Dodge R.K., Charles H.C., Samulski T.V., Prosnitz L.R., Dewhirst M.W. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res. 56:1996;5347-5350.
11. Okajima K., Griffin R.J., Iwata K., Shakil A., Song C.W. Tumor oxygenation after mild temperature hyperthermia in combination with carbogen breathing dependence on heat dose and tumor type . Radiat. Res. 149:1998;294-299.
12. Song C.W., Shakil A., Osborn J.L., Iwata K. Tumor oxygenation is increased by hyperthermia at mild temperatures. Int. J. Hyperthermia. 12:1996;367-373.
13. 2 can be increased markedly by mild hyperthermia. Br. J. Cancer. 74:1996;S217-S221.
14. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines tumour bioenergetic status and blood flow . Br. J. Cancer. 68:1993;1061-1070.
15. 31P NMR spectroscopy and microelectrodes. Radiat. Res. 127:1991;177-183.
16. Naruse S., Higuchi T., Horikawa Y., Tanaka C., Nakamura K., Hirakawa K. Radiofrequency hyperthermia with successive monitoring of its effects on tumors using NMR spectroscopy. Proc. Natl. Acad. Sci. USA. 83:1986;8343-8347.
17. 31P NMR spectroscopy of in vivo tumors. J. Magn. Reson. 49:1982;271-286.
18. 31P-nuclear magnetic resonance spectroscopy. Cancer Res. 47:1987;6467-6473.
19. 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia. Proc. Natl. Acad. Sci. USA. 80:1983;331-338.
20. 31P-nuclear magnetic resonance spectroscopy in vivo of four human melanoma xenograft lines Spin-lattice relaxation times . Radiother. Oncol. 32:1994;54-62.
21. 31P-MRS. Magn. Reson. Imaging. 15:1997;1187-1192.
22. 31P MRS: Correlation of longitudinal relaxation with tumor growth rate and DNA synthesis. Int. J. Radiat. Oncol. Biol. Phys. 14:1988;1185-1195.
23. 31P-magnetic resonance spectroscopy. Influence of oxygen tension. Acta. Oncol. 34:1995;339-343.
24. Rofstad E.K., Wahl A., Stokke T., Nesland J.M. Establishment and characterization of six human melanoma xenograft lines. APMIS. 98:1990;945-953.
25. 1 determination by inversion-recovery. J. Magn. Reson. 77:1988;483-490.
26. 31P-nuclear magnetic resonance spectroscopy studies of tumor energy metabolism and its relationship to intracapillary oxyhemoglobin saturation and tumor hypoxia. Cancer Res. 48:1988;5440-5446.
27. Appelgren L.K. Methods of recording tumor blood flow. Peterson H.I. Tumor Blood Circulation. 1979;97-100 CRC Press, Boca Raton.
28. Sapirstein L.A. Regional blood flow by fractional distribution of indicators. Am. J. Physiol. 193:1958;161-168.
29. Gullino P.M., Grantham F.H. Studies of the exchange of fluids between host and tumors. II. The blood flow of hepatomas and other tumors in rats and mice. J. Natl. Cancer Inst. 24:1961;1465-1491.
30. Lyng H., Skretting A., Rofstad E.K. Blood flow in six human melanoma xenograft lines with different growth characteristics. Cancer Res. 52:1992;584-592.
31. Lyng H., Dahle G.A., Kaalhus O., Skretting A., Rofstad E.K. Measurement of perfusion rate in human melanoma xenografts by contrast-enhanced magnetic resonance imaging. Magn. Reson. Med. 40:1998;89-98.
32. Demsar F., Roberts T.P.L., Schwickert H.C., Shames D.M., Van Dijke C.F., Mann J.S., Saeed M., Brasch R.C. A MRI spatial mapping technique for micro-vascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn. Reson. Med. 37:1997;236-242.
33. Su M.Y., Mühler A., Lao X., Nalcioglu O. Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn. Reson. Med. 39:1998;259-269.
34. 31P MRS. NMR Biomed. 9:1996;208-216.
35. Robinson S.P., Rodrigues L.M., Ojugo A.S.E., McSheehy P.M.J., Howe F.A., Griffiths J.R. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. Br. J. Cancer. 75:1997;1000-1006.